REFERENCES
1. Schadendorf D, Lebbé C, zur Hausen A, Avril M-F, Hariharan S, Bharmal M, et al. Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs. European Journal of Cancer. 2017;71:53-69.
2. Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, et al. Merkel cell carcinoma. Nature Reviews Disease Primers. 2017;3:17077.
3. Higaki-Mori H, Kuwamoto S, Iwasaki T, Kato M, Murakami I, Nagata K, et al. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Human pathology. 2012;43(12):2282-91.
4. Church CD, Nghiem P. How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model. The Journal of investigative dermatology. 2015;135(5):1221-4.
5. Wong SQ, Waldeck K, Vergara IA, Schröder J, Madore J, Wilmott JS, et al. UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas. Cancer research. 2015;75(24):5228-34.
6. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. New England Journal of Medicine. 1998;339(17):1247-8.
7. Amaral T, Leiter U, Garbe C. Merkel cell carcinoma: epidemiology, pathogenesis, diagnosis and therapy. Reviews in Endocrine and Metabolic Disorders. 2017;18(4):517-32.
8. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. Journal of clinical oncology. 2002;20(2):588-98.
9. McAfee WJ, Morris CG, Mendenhall CM, Werning JW, Mendenhall NP, Mendenhall WM. Merkel cell carcinoma: treatment and outcomes. Cancer. 2005;104(8):1761-4.
10. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. Journal of the American Academy of Dermatology. 2003;49(5):832-41.
11. Llombart B, Requena C, Cruz J. Update on Merkel cell carcinoma: epidemiology, etiopathogenesis, clinical features, diagnosis, and staging. Actas Dermo-Sifiliográficas (English Edition). 2017;108(2):108-19.
12. Linjawi A, Jamison WB, Meterissian S. Merkel cell carcinoma: important aspects of diagnosis and management. The American surgeon. 2001;67(10):943.
13. Oh SI, Jin US, Chang H, Kwon ST, Minn KW. A retrospective analysis of eight cases of Merkel cell carcinoma. Archives of Craniofacial Surgery. 2013;14(1):41-5.
14. An KP, Ratner D. Merkel cell carcinoma in the setting of HIV infection. Journal of the American Academy of Dermatology. 2001;45(2):309-12.
15. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Annals of surgical oncology. 2001;8(3):204-8.
16. Xue Y, Thakuria M. Merkel cell carcinoma review. Hematology/Oncology Clinics. 2019;33(1):39-52.
17. Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, et al. Merkel cell carcinoma. Nature reviews Disease primers. 2017;3(1):1-17.
18. Tello TL, Coggshall K, Yom SS, Yu SS. Merkel cell carcinoma: An update and review: Current and future therapy. J Am Acad Dermatol. 2018;78(3):445-54.
19. Barreira JV, Valejo Coelho MM. Unknown primary Merkel cell carcinoma with cutaneous spread. 2019;12(2).
20. Agut-Busquet E, Yebenes M, Luelmo J. Stony-Hard Subcutaneous Mass on the Arm of a Young Woman. Actas dermo-sifiliograficas. 2016;107(2):149-50.
21. Leroux-Kozal V, Lévêque N, Brodard V, Lesage C, Dudez O, Makeieff M, et al. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. Human pathology. 2015;46(3):443-53.
22. Panse G, McNiff JM, Ko CJ. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma. Journal of cutaneous pathology. 2017;44(6):553-6.
23. Kontochristopoulos GJ, Stavropoulos PG, Krasagakis K, Goerdt S, Zouboulis CC. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study. Dermatology (Basel, Switzerland). 2000;201(2):123-6.
24. Battifora H, Silva EG. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma. Cancer. 1986;58(5):1040-6.
25. Sur M, AlArdati H, Ross C, Alowami S. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2007;20(11):1113-20.
26. Fernandez-Flores A, Suarez-Penaranda JM, Alonso S. Study of EWS/FLI-1 rearrangement in 18 cases of CK20+/CM2B4+ Merkel cell carcinoma using FISH and correlation to the differential diagnosis of Ewing sarcoma/peripheral neuroectodermal tumor. Applied immunohistochemistry & molecular morphology : AIMM. 2013;21(5):379-85.
27. Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pföhler C, et al. Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe. Oncotarget. 2017;8(45):79731.
28. Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, et al. Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy. Journal of Clinical Oncology. 2019;37(9):693.